Close
Close

Anti-Peptide ESL T cell receptor (OT-II), pCDTCR1 (TCR-YC0897)

 Datasheet

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

The vector of anti-Peptide ESL T cell receptor (TCR) is constructed for the engineering of T cell to target Peptide ESL (ESLKISQAVHAAHAEINEAGRAAAAAK + GLYC(K27)) restricted by H2 class II. The T cells are genetically modified through transduction with a lentiviral vector expressing Peptide ESL-specific T cell receptor.

Specific Inquiry

  • Size:
  • Marker:
  • Form:
  Add to Cart

Details

  • Target
  • Peptide ESL
  • Epitope
  • ESLKISQAVHAAHAEINEAGRAAAAAK + GLYC(K27)
  • Format
  • Non-Modified TCR
  • Allele
  • H2 class II
  • Vector Name
  • pCDTCR1
  • Vector Length
  • ~ 8 kb
  • Vector Type
  • Lentiviral vector
  • TCR Clone
  • OT-II
  • Host Species
  • Mouse

Target

  • Introduction
  • Vaccination with synthetic long peptides (SLPs), covering viral or tumor epitopes, has shown promising results in experimental models and recently also in clinical therapeutic vaccination trials. This peptide-based vaccine platform allows covering multiple (overlapping) MHC classes I and II epitopes and therefore does not require the necessity for HLA-typing for each patient to be treated. Moreover, in contrast to short peptides, SLPs are not able to bind directly to MHC class I and their presentation to CD8+ T cells therefore requires uptake and processing by antigen-presenting cells (APCs) such as dendritic cells (DCs) before they are presented. This is advantageous, as properly activated dendritic cells (DCs) are vital for the strength of the ensuing T-cell responses. Other immune cells for example generally lack the capacity to provide adequate T cell costimulation and thus may cause tolerance. The efficacy of a particular peptide vaccine is however influenced by many parameters and its success ranges from inducing clinical efficacy to detrimental effects such as hyperreactivity and hyporesponsiveness. Mechanistic studies with peptide vaccines in different experimental models revealed that by more specific targeting, improving the uptake of SLPs, and/or activation of APCs the SLP-based vaccines generally advance leading to better clinical success.

Customer Reviews and Q&As

There are currently no customer reviews or questions for Mouse anti-Peptide ESL T cell receptor (OT-II), pCDTCR1 (TCR-YC0897). Click the button below to contact us or submit your feedback about this product.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Related Products

Breast cancer

Pancreatic cancer

Others

TCR Vector Products

Autoimmune Diseases

Melanoma

Lung malignancy

GIST

Viral Infection

Online Inquiry
Products
Global Services
Online Inquiry

For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.
Copyright © 2024 Creative Biolabs. All Rights Reserved
Cart
    Go to checkout